WITHDRAWN: Executive Summary - The International Society for Heart and Lung
Transplantation (ISHLT) guidelines for the care of heart transplant recipients - ScienceDirect Skip …

The first human heart transplantation was performed by Christian Barnard in 1967. While the
technical aspect had been worked out, allograft rejection was a major limitation in the early …

Heart transplantation (HT) is the definitive treatment for eligible patients with end‐stage
heart disease. A major complication of HT is allograft rejection which can lead to graft …

Background Induction immunosuppression in heart transplant recipients varies greatly by
center. Basiliximab (BAS) is the most commonly used induction immunosuppressant but has …

Heart transplant prolongs life for patients with end-stage heart failure but rejection remains a
complication that reduces long-term survival. The aim is to provide a comprehensive …

Introduction Induction therapy (IT) utility in heart transplantation (HT) remains contested.
Commissioned by a clinical‐practice guidelines panel to evaluate the effectiveness and …

Introduction This study analyzes heart transplantation funding provided by the National
Natural Science Foundation of China (NSFC) between 1986 and 2022. The findings offer an …

Background Patients undergoing heart transplants are at risk of rejection which can have
significant morbidity and mortality. Induction immunosuppression at the time of transplant …

心脏移植是治疗终末期心力衰竭最有效的策略之一. 心脏同种移植面临供心保存困难,
排斥反应和术后并发症多等诸多问题. 经过数十年的研究和实践, 大多问题已得到解决 …

Background: Atherosclerosis is a significant cause of coronary heart disease, cerebral
infarction, and peripheral vascular disease. The objective of this study was to identify the key …